undamentalytics Newsletter
Sign in

Beta Bionics, Inc. revenue

Beta Bionics, Inc.'s revenue was $100m in fiscal 2025, up 53.9% on the year before. Over the last twelve months it was $127m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue1265100127
Growth on the year before—+442.9%+53.9%—
Gross profit6365675
Gross margin52.6%55.1%55.4%58.6%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Beta Bionics, Inc. $127m 43.7% —
Rxsight, Inc. $128m -13.2% 23.9%
Anika Therapeutics, Inc. $121m 5.3% 0.3%
Outset Medical, Inc. $118m -1.3% -3.1%
Owlet, Inc. $115m 28.2% 29.3%
Infusystem Holdings, Inc $143m 2.5% 6.6%

Compare with peers

Head to head: BBNX vs RXSTANIK vs BBNXBBNX vs OMBBNX vs INFU

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Beta Bionics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Beta Bionics, Inc.